Guardant Health Inc at Citi Healthcare Conference (Virtual) Transcript
Okay. Great. Thank you, everyone, for joining us at the Citi Healthcare Conference here. I'm Patrick Donnelly, I cover the tools diagnostics space here at Citi. Happy to have the Guardant team. We have Helmy, AmirAli and Mike, so the co-CEOs and CFO with us. So we'll look to cover a lot of ground.
Obviously topical coming off of the report just last night. So again, thank you guys for the quick turnaround and joining us today. Maybe we can start just touching on the quarter again since it was just last night. And maybe one for you, Helmy, he's reported really strong revenue, $108 million, well above the Street. And the test volumes, particularly were quite strong in -- particularly in the face of the COVID outbreak, Omicron popping up at the end of the quarter there. Can you just talk about, I guess, the resilience of the business to that? And again, it didn't really feel like it impacted things. So again, the momentum as we enter '22 here would be helpful.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |